Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan;48 Suppl 1(Suppl 1):19-30.
doi: 10.1111/jvp.13466. Epub 2024 Jul 2.

SGLT2 inhibitor use in the management of feline diabetes mellitus

Affiliations
Review

SGLT2 inhibitor use in the management of feline diabetes mellitus

Audrey K Cook et al. J Vet Pharmacol Ther. 2025 Jan.

Abstract

Sodium-glucose cotransporter-2 (SGLT2) inhibitors are routinely used in the management of human type 2 diabetes and have been shown to effectively mitigate hyperglycemia and reduce the risks of cardiovascular and renal compromise. Two SGLT2 inhibitors, namely bexagliflozin and velagliflozin, were recently FDA approved for the treatment of uncomplicated feline diabetes mellitus. These oral hypoglycemic agents are a suitable option for many newly diagnosed cats, with rapid improvements in glycemic control and clinical signs. Suitable candidates must have some residual β-cell function, as some endogenous insulin production is required to prevent ketosis. Appropriate patient selection and monitoring are necessary, and practitioners should be aware of serious complications such as euglycemic diabetic ketoacidosis.

Keywords: bexagliflozin; cat; diabetes; velagliflozin.

PubMed Disclaimer

Conflict of interest statement

Dr. Audrey Cook and Dr. Ellen Behrend are paid consultants for Boehringer Ingelheim. Dr. Audrey Cook is a paid consultant for Elanco Animal Health.

References

    1. Albuquerque, C. S. , Bauman, B. L. , Rzeznitzeck, J. , Caney, S. M. , & Gunn‐Moore, D. A. (2020). Priorities on treatment and monitoring of diabetic cats from the owners' points of view. Journal of Feline Medicine and Surgery, 22(6), 506–513. - PMC - PubMed
    1. American Diabetes Association American Diabetes Association: Diabetes and Statistics. https://diabetes.org/about‐diabetes/statistics
    1. Avgerinos, I. , Karagiannis, T. , Kakotrichi, P. , Michailidis, T. , Liakos, A. , Matthews, D. R. , Tsapas, A. , & Bekiari, E. (2022). Sotagliflozin for patients with type 2 diabetes: A systematic review and meta‐analysis. Diabetes, Obesity & Metabolism, 24(1), 106–114. - PubMed
    1. Bailiff, N. L. , Nelson, R. W. , Feldman, E. C. , Westropp, J. L. , Ling, G. V. , Jang, S. S. , & Kass, P. H. (2006). Frequency and risk factors for urinary tract infection in cats with diabetes mellitus. Journal of Veterinary Internal Medicine, 20(4), 850–855. - PubMed
    1. Bazelle, J. , & Watson, P. (2014). Pancreatitis in cats: Is it acute, is it chronic, is it significant? Journal of Feline Medicine and Surgery, 16(5), 395–406. - PMC - PubMed

MeSH terms

Substances